Found 8 results
Name | Type of Offering | Accepted Date |
---|---|---|
Aclipse Therapeutics LLC
See All Filings
|
D/A | 2019-03-22 16:42:05 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001730907
Filed Document
0001730907-19-000003
Exclusions or Exemptions
506b
Accepted Date
2019-03-22 16:42:05
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Aclipse Therapeutics LLC
See All Filings
|
D | 2020-03-23 17:05:24 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001730907
Filed Document
0001730907-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-03-23 17:05:24
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Other
|
||
Aclipse Therapeutics LLC
See All Filings
|
D | 2019-03-22 16:44:07 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001730907
Filed Document
0001730907-19-000004
Exclusions or Exemptions
506b
Accepted Date
2019-03-22 16:44:07
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Other
|
||
Aclipse Therapeutics LLC
See All Filings
|
D | 2020-08-24 12:51:34 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001730907
Filed Document
0001730907-20-000002
Exclusions or Exemptions
506b
Accepted Date
2020-08-24 12:51:34
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Aclipse Therapeutics LLC
See All Filings
|
D/A | 2019-02-15 10:41:50 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001730907
Filed Document
0001730907-19-000002
Exclusions or Exemptions
506b
Accepted Date
2019-02-15 10:41:50
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Aclipse Therapeutics LLC
See All Filings
|
D | 2018-02-15 15:36:47 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001730907
Filed Document
0001437377-18-000002
Exclusions or Exemptions
506b
Accepted Date
2018-02-15 15:36:47
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Aclipse Therapeutics LLC
See All Filings
|
D/A | 2018-10-26 11:41:41 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001730907
Filed Document
0001730907-18-000002
Exclusions or Exemptions
506b
Accepted Date
2018-10-26 11:41:41
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Aclipse Therapeutics LLC
See All Filings
|
D | 2019-06-19 13:16:44 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001730907
Filed Document
0001730907-19-000005
Exclusions or Exemptions
506b
Accepted Date
2019-06-19 13:16:44
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Other
|